首页> 外国专利> Quinuclidine derivatives and their use as muscarinic M3 receptor ligands.

Quinuclidine derivatives and their use as muscarinic M3 receptor ligands.

机译:奎尼丁衍生物及其作为毒蕈碱M3受体配体的用途。

摘要

A compound according to formula (I) wherein: custom-character file="US20030055080A1-20030320-P00900.TIF" wi="20" he="20" id="custom-character-00001"/is a phenyl ring, a C4 to C9 heteroaromatic compound containing one or more heteroatoms, or a naphthalenyl, 5,6,7,8-tetrahydronaphthalenyl or biphenyl group; R1, R2 and R3 each independently represent a hydrogen or halogen atom, or a hydroxy group, or a phenyl, -OR4, -SR4, -NR4R5, -NHCOR4, -CONR4R5, -CN, -NO2, -COOR4 or -CF3 group, or a straight or branched lower alkyl group which may optionally be substituted, for example, with a hydroxy or alcoxy group, wherein R4 and R5 each independently represent a hydrogen atom, straight or branched lower alkyl group, or together form an alicyclic ring; or R1 and R2 together form an aromatic, alicyclic or heterocyclic ring; n is an integer from 0 to 4; A represents a -CH2-, -CH=CR6, -CR6=CH-, -CR6R7-, -CO-, -O-, -S-, -S(O)-, SO2 or -NR6- group, wherein R6 and R7 each independently represent a hydrogen atom, straight or branched lower alkyl group, or R6 and R7 together form an alicyclic ring; m is an integer from 0 to 8; provided that when m=0, A is not -CH2-; p is an integer from 1 to 2 and the substitution in the azoniabicyclic ring may be in the 2, 3 or 4 position including all possible configurations of the asymmetric carbons; B represents a group of formula i) or ii): wherein R10 represents a hydrogen atom, a hydroxy or methyl group; and R8 and R9 each independently represents wherein R11 represents a hydrogen or halogen atom, or a straight or branched lower alkyl group and Q represents a single bond, -CH2-, -CH2-CH2-, -O-, -O-CH2-, -S-, -S-CH2- or -CH=CH-, and when i) or ii) contain a chiral centre they may represent either configuration; X represents a pharmaceutically acceptable a
机译:根据式(I)的化合物,其中:是苯环; C4至C9杂芳族化合物,其包含一个或多个杂原子,或萘基,5,6,7,8-四氢萘基或联苯基; R 1,R 2和R 3各自独立地表示氢或卤素原子或羟基,或苯基,-OR 4,-SR 4,-NR 4 R 5,-NHCOR 4,-CONR 4 R 5,-CN,-NO 2,-COOR 4或-CF 3基团。 ;或直链或支链的低级烷基,其可任选地被例如羟基或烷氧基取代,其中R 4和R 5各自独立地代表氢原子,直链或支链的低级烷基,或一起形成脂环族环; R 1和R 2一起形成芳族,脂环族或杂环; n是0至4的整数; A代表-CH2-,-CH = CR6,-CR6 = CH-,-CR6R7-,-CO-,-O-,-S-,-S(O)-,SO2或-NR6-基团,其中R6 R 7和R 7各自独立地表示氢原子,直链或支链的低级烷基,或R 6和R 7一起形成脂环族环。 m是0至8的整数;假设当m = 0时,A不是-CH 2-; p是1至2的整数,并且在氮杂双环中的取代可以在2、3或4位,包括不对称碳的所有可能的构型; B代表式i)或ii)的基团:其中R 10代表氢原子,羟基或甲基; R 8和R 9各自独立地表示式中,R 11表示氢或卤素原子,或直链或支链的低级烷基,Q表示单键,-CH 2-,-CH 2 -CH 2-,-O-,-O-CH 2-。 ,-S-,-S-CH 2-或-CH = CH-,并且当i)或ii)包含手性中心时,它们可以代表任一种构型; X代表药学上可接受的

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号